- Home
- SLRX vs FOXO Comparison
SLRX vs FOXO Comparison
Compare SLRX & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLRX
- FOXO
- Stock Information
- Founded
- SLRX N/A
- FOXO 2019
- Country
- SLRX United States
- FOXO United States
- Employees
- SLRX N/A
- FOXO N/A
- Industry
- SLRX Biotechnology: Pharmaceutical Preparations
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- SLRX Health Care
- FOXO Technology
- Exchange
- SLRX Nasdaq
- FOXO Nasdaq
- Market Cap
- SLRX 2.5M
- FOXO 2.4M
- IPO Year
- SLRX N/A
- FOXO N/A
- Fundamental
- Price
- SLRX $1.37
- FOXO $0.53
- Analyst Decision
- SLRX
- FOXO
- Analyst Count
- SLRX 0
- FOXO 0
- Target Price
- SLRX N/A
- FOXO N/A
- AVG Volume (30 Days)
- SLRX 42.5K
- FOXO 143.7M
- Earning Date
- SLRX 11-14-2024
- FOXO 08-19-2024
- Dividend Yield
- SLRX N/A
- FOXO N/A
- EPS Growth
- SLRX N/A
- FOXO N/A
- EPS
- SLRX N/A
- FOXO N/A
- Revenue
- SLRX N/A
- FOXO $1,341,000.00
- Revenue This Year
- SLRX N/A
- FOXO N/A
- Revenue Next Year
- SLRX N/A
- FOXO N/A
- P/E Ratio
- SLRX N/A
- FOXO N/A
- Revenue Growth
- SLRX N/A
- FOXO N/A
- 52 Week Low
- SLRX $1.26
- FOXO $0.13
- 52 Week High
- SLRX $7.27
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- SLRX 41.48
- FOXO 52.56
- Support Level
- SLRX $1.37
- FOXO $0.55
- Resistance Level
- SLRX $1.44
- FOXO $0.84
- Average True Range (ATR)
- SLRX 0.07
- FOXO 0.27
- MACD
- SLRX -0.01
- FOXO -0.01
- Stochastic Oscillator
- SLRX 15.61
- FOXO 33.61
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.